The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Numerous longevity genes have been discovered in model organisms and altering their function results in prolonged lifespan. In mammals, some have speculated that any health benefits derived from manipulating these same pathways might be offset by increased cancer risk on account of their propensity to boost cell survival. The Sir2/SIRT1 family of NAD(+)-dependent deacetylases is proposed to underlie the health benefits of calorie restriction (CR), a diet that broadly suppresses cancer in mammals. Here we show that CR induces a two-fold increase SIRT1 expression in the intestine of rodents and that ectopic induction of SIRT1 in a beta-catenin-driven mouse model of colon cancer significantly reduces tumor formation, proliferation, and animal morbidity in the absence of CR. We show that SIRT1 deacetylates beta-catenin and suppresses its ability to activate transcription and drive cell proliferation. Moreover, SIRT1 promotes cytoplasmic localization of the otherwise nuclear-localized oncogenic form of beta-catenin. Consistent with this, a significant inverse correlation was found between the presence of nuclear SIRT1 and the oncogenic form of beta-catenin in 81 human colon tumor specimens analyzed. Taken together, these observations show that SIRT1 suppresses intestinal tumor formation in vivo and raise the prospect that therapies targeting SIRT1 may be of clinical use in beta-catenin-driven malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“We and other researchers have gathered compelling evidence, from yeast to mammals, supporting the idea that a loss of epigenetic information, resulting in changes in gene expression, leads to the loss of cellular identity [3–7].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · cited 1×
“b-catenin is the central effector in the canonical Wnt signaling pathway that controls stem cell maintenance, development and carcinogenesis [20].”
BackgroundActivation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905 · cited 1×
“. Constitutive activation of the β-catenin pathway has been found in 90% of colorectal cancers”
BackgroundModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“On the other hand, SIRT1 can be proapoptotic [12] and anti-proliferative [13,14], and consequently has been proposed to behave as a tumor suppressor in vivo.”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationIncreased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564 · cited 2×
“Interestingly, two recent studies have shown that increased Wnt signaling is associated with accelerated aging, suggesting that an attenuation of Wnt signaling might underlie CR and be beneficial not only for treating cancer but for more broadly attenuating diseases of aging [23,24].”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Self-citationAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“of the second allele leads to constitutive nuclear localization of bcatenin and adenoma formation [18,19].”
BackgroundSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Cited by
Items 401–500 of 603
Rahman, S., Alhallaj, A., Nedhi, A., Gmati, G., Abuelgasim, K. A., Jama, H. A., Trivilegio, T., Mashour, A., Alaskar, A., & Boudjelal, M. (2017) · Journal of Circadian Rhythms · doi:10.5334/jcr.147 · Cited by 19
Chen, X., Lai, X., Wu, C., Tian, Q., Lei, T., Pan, J., & Huang, G. (2017) · Cancer Biomarkers · doi:10.3233/cbm-160419 · Cited by 18
“Moreover, SIRT1 expression in the mouse APC min / + model inhibits the formation of intestinal tumors [21].”
Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma
Feng, H., Guo, P., Wang, J., Xu, J., Xie, C., & Gao, F. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.02.002 · Cited by 17
Physical Activity, Dietary Calorie Restriction, and Cancer
McTiernan, A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7551-5 · Cited by 17
“In the five cohort studies that did not adjust for BMI [243, 244, 245, 246, 247], the median relative risk for the association of physical activity with pancreatic cancer incidence was 1.”
BackgroundSIRT1 and the Clock Gene Machinery in Colorectal Cancer
Pazienza, V., Piepoli, A., Panza, A., Valvano, M. R., Benegiamo, G., Vinciguerra, M., Andriulli, A., & Mazzoccoli, G. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.640650 · Cited by 20
“Besides, SIRT1 deacetylates β-catenin and suppresses its ability to activate transcription and drive cell proliferation (52).”
BackgroundLactobacillus brevis T2102 suppresses the growth of colorectal cancer cells by activating SIRT1
Harada, G., Pattarawat, P., Ito, K., Matsumoto, T., Hasegawa, T., & Katakura, Y. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.01.016 · Cited by 17
Novel 1,4-dihydropyridine induces apoptosis in human cancer cells through overexpression of Sirtuin1
Manna, D., Bhuyan, R., Saikh, F., Ghosh, S., Basak, J., & Ghosh, R. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1483-6 · Cited by 19
miRNA regulation of Sirtuin-1 expression in human astrocytoma
Romeo, S., Conti, A., Polito, F., Tomasello, C., Barresi, V., Torre, D. L., Cucinotta, M. D., Angileri, F. F., Bartolotta, M., Giorgio, R. M. D., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.4960 · Cited by 18
“…types of cancers, including lymphomas, leukemia, prostate, breast, intestine and colon cancers, and the effect of sirtuins on the expression of proteins involved in tumorigenesis, such as p53, p73, nuclear factor-κ B (NF-κ B) and forkhead box subgroup O (FOXO), has been well studied (9-15).”
InfluentialSIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells
García-Martínez, J. M., Chocarro‐Calvo, A., Martínez‐Useros, J., Regueira-Acebedo, N., Fernández‐Aceñero, M. J., Múñoz, A., Larriba, M. J., & García‐Jiménez, C. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95875 · Cited by 17
“…in certain tumours, suggesting that SIRT1 acts as tumour promoter, Wang et al. [51] reported that SIRT1-deficient embryos exhibit genomic instability and increased tumourigenesis, and Firestein et al. [52] showed that SIRT1 suppressed tumour growth in a mouse CRC model driven by Wnt/β -catenin.”
BackgroundHuang, G., Lin, Y., & Zhu, G. (2017) · PubMed · Cited by 16
Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine
Manna, D., Bhuyan, R., & Ghosh, R. (2018) · Journal of Molecular Modeling · doi:10.1007/s00894-018-3877-3 · Cited by 17
The effect of caloric restriction on genetical pathways
Karagöz, M. F., & Celep, G. S. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.02.007 · Cited by 17
The role of structural biology in the design of sirtuin activators
Fiorentino, F., Mai, A., & Rotili, D. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102666 · Cited by 17
Beton-Mysur, K., & Brożek-Płuska, B. (2023) · Analytical Methods · doi:10.1039/d3ay01040f · Cited by 15
Lahousse, S. A., Hoenerhoff, M. J., Collins, J., Ton, T.-V. T., Masinde, T., Olson, D. M., Rebolloso, Y., Koujitani, T., Tomer, K. B., Hong, H.-H. L., et al. (2010) · Veterinary Pathology · doi:10.1177/0300985810390019 · Cited by 15
García‐Jiménez, C. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00014-x · Cited by 15
The Role of Sirt1 in Bile Acid Regulation during Calorie Restriction in Mice
Fu, Z. D., Cui, J. Y., & Klaassen, C. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138307 · Cited by 15
“This is different from a previous report that CR induced a 2-fold increase in Sirt1 protein in the intestine of rats [44].”
He, Z., Yi, J., Jin, L., Pan, B., Chen, L., & Song, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4459-y · Cited by 15
“Indeed, SIRT1 has been reported to suppress the growth of colon cancer [14], breast cancer [15], and pancreatic cancer [16].”
BackgroundShi, X., Zhao, Y., Ding, C., Wang, Z., Ji, A., Li, Z., Feng, D., Li, Y., Gao, D., Zhou, J., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.04.036 · Cited by 16
TERAMAE, M., Fukuda, T., Wada, T., Kawanishi, M., IMAI, K., Yamauchi, M., Yasui, T., & Sumi, T. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.427 · Cited by 15
Sirtuin1 in vascular endothelial function, an overview
Kumar, J., & Kumar, S. (2021) · Epigenetics · doi:10.1080/15592294.2021.1975936 · Cited by 14
“catenin [144], RelA/p65 [32,145], PGC1α [43],”
Murofushi, T., Tsuda, H., Mikami, Y., Yamaguchi, Y., & Suzuki, N. (2017) · Journal of Oral Science · doi:10.2334/josnusd.16-0696 · Cited by 14
Han, C., Wan, H., Ma, S., Liu, D., He, F., Wang, J., Pan, Z., Liu, H., Li, L., He, H., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.10.012 · Cited by 15
RetractedBushell, W. C., & Theise, N. D. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04959.x · Cited by 15
Kang, X., Kong, B., Chen, Q., & Zhao, S. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-559 · Cited by 14
“However, some studies shown that SIRT1 could inhibit tumor progression (38,39).”
BackgroundClark-Knowles, K. V., Dewar‐Darch, D., Jardine, K. E., & McBurney, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082106 · Cited by 15
“Although the results reported in this communication are consistent with our previous work [16] that found that SIRT1null mice were not differentially sensitive to oncogenic treatments, these results are at odds with other reports [8,9] that suggest that SIRT1 has tumor suppressive properties.”
ResultHan, F., Zhang, S., Liang, J., & Qiu, W. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.03.018 · Cited by 13
Park, J. Y., Han, S., Ka, H. I., Joo, H. J., Soh, S., Yoo, K. H., & Yang, Y. (2019) · Cancer Science · doi:10.1111/cas.14147 · Cited by 13
SIRT1 enhances hepatitis virus B transcription independent of hepatic autophagy
Yamai, T., Hikita, H., Fukuoka, M., Fukutomi, K., Murai, K., Nakabori, T., Yamada, R., Miyakawa, K., Watashi, K., Ryo, A., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.031 · Cited by 13
Berclaz, L. M., Altendorf-Hofmann, A., Dürr, H. R., Klein, A., Angele, M. K., Albertsmeier, M., Schmidt-Hegemann, N.-S., Gioia, D. D., Knösel, T., & Lindner, L. H. (2021) · Cancers · doi:10.3390/cancers13194877 · Cited by 13
“These studies were conducted on other cancer types, including breast, ovarian and colon cancer, which limits their comparison to our results [32,33].”
ResultSirtuins in Aging and Age-Related Diseases
Haigis, M. C., & Sinclair, D. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00011-7 · Cited by 14
Self-citationPrognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis
Jiang, B., Chen, J., Yuan, W., Ji, J., Liu, Z.-Y., Wu, L., Tang, Q., & Shu, X. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1580-0 · Cited by 12
Synthesis and Assay of SIRT1-Activating Compounds
Dai, H., Ellis, J. L., Sinclair, D. A., & Hubbard, B. P. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.01.012 · Cited by 14
Self-citationTang, B. L. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.2.10972 · Cited by 12
Sirtuins and Cancer: New Insights and Cell Signaling
de Oliveira, M. V. M., Andrade, J. M. O., Paraíso, A. F., & Santos, S. H. S. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.853076 · Cited by 13
“inhibited (increased tumorigenesis) or overexpressed (attenuated tumorigenesis) (15, 16).”
Distinct effects of SIRT1 in cancer and stromal cells on tumor promotion
Shin, D. H., Choi, Y.-J., Jin, P., Yoon, H., Chun, Y., Shin, H., Kim, J., & Park, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8073 · Cited by 14
“According to previous literatures, it is speculated that SIRT1 inhibits cell growth by targeting the Wnt/β-catenin, NF-κ B, or HIF-1 signaling pathway [21-23].”
Sirtuins, Healthspan, and Longevity in Mammals
Giblin, W., & Lombard, D. B. (2016) · Handbook of the Biology of Aging · doi:10.1016/b978-0-12-411596-5.00003-4 · Cited by 12
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β
Parija, M., Prakash, S., Krishna, B. M., Dash, S., & Mishra, S. K. (2024) · Breast Cancer · doi:10.1007/s12282-024-01555-9 · Cited by 11
“Recent studies suggested that SIRT1 acts as a tumor suppressor in colon cancer cells by repressing the activity of β-catenin [20] and survivin [21].”
Otsuka, R., Sakata, H., Murakami, K., Kano, M., Endo, S., Toyozumi, T., Matsumoto, Y., SUITO, H., Takahashi, M., Sekino, N., et al. (2022) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10086 · Cited by 11
Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
Xiao, T., Chen, Z., Xie, Y., Yang, C., Wu, J., & Gao, L. (2024) · Therapeutic Advances in Hematology · doi:10.1177/20406207241283277 · Cited by 15
“10 Class I HDACs (HDAC1, 2, 3, 8) are most closely related to reduced potassium dependency 3 (RPD3) and are the most abundant HDACs located in the cell nucleus.”
BackgroundPromising drug discovery strategies for sirtuin modulators: what lessons have we learnt?
Garg, G., Singh, A. K., Singh, S., & Rizvi, S. I. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1915980 · Cited by 13
“The downregulated level of SIRT1 has been observed in many cancers [48].”
BackgroundZhang, Y., Cai, X., Chai, N., Gu, Y., Zhang, S., Ding, M., Cao, H., Sha, S., Yin, J., Li, M., et al. (2015) · Gastrointestinal Tumors · doi:10.1159/000441460 · Cited by 11
Impacts on Sirtuin Function and Bioavailability of the Dietary Bioactive Compound Dihydrocoumarin
Jacobi, J. L., Yang, B. H., Li, X., Menze, A. K., Laurentz, S., Janle, E. M., Ferruzzi, M. G., McCabe, G. P., Chapple, C. C. S., & Kirchmaier, A. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149207 · Cited by 11
Upregulation of SIRT1 gene in gastric adenocarcinoma
Özcan, Ö., Bellı, A. K., Çetin, E. S., Kara, M., Çelik, Ö. İ., Kaplan, M., Kayılıoğlu, S. İ., Dönmez, C., & Polat, M. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18550 · Cited by 11
Identification of longevity genes with systems biology approaches
Tang, F. (2009) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s4070 · Cited by 10
Pawlik, M. T., Rinneberg, G., Koch, A., Meyringer, H., Loew, T. H., & Kjellberg, A. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01911-y · Cited by 11
Grande, I. P. P., Amorim, P. V. G. H., Freire, A. C. T. B., Jallad, R. S., Musolino, N. R. D. C., Cescato, V. Â. S., da Silva, G. O., Bronstein, M. D., & Trarbach, E. B. (2018) · Pituitary · doi:10.1007/s11102-018-0881-7 · Cited by 13
Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer
Lee, G. J., Jung, Y. H., Kim, T. J., Chong, Y., Jeong, S.-W., Lee, I. K., & Woo, I. S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.249 · Cited by 12
Anti-aging protein SIRT1: A role in cervical cancer?
Brooks, C. L., & Gu, W. J. (2009) · Aging · doi:10.18632/aging.100031 · Cited by 10
“The growth suppressing observations in vivo, therefore, could be attributed to the genetic context of p53 [6].”
BackgroundMechanistic perspectives of calorie restriction on vascular homeostasis
Liu, Y., Chen, H., & Liu, D. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4709-z · Cited by 10
Tomita, M. (2012) · Journal of Carcinogenesis · doi:10.4103/1477-3163.99176 · Cited by 10
“It has been shown that SIRT1 overexpression inhibits the growth of colon cancer cells dependent on β-catenin activity, suppresses the localization of β-catenin to the nucleus, and significantly attenuates its ability to activate transcription.[22]”
BackgroundInfluentialKhadempar, S., Lotfi, M., Haghiralsadat, F., Saidijam, M., Ghasemi, N., & Afshar, S. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107518 · Cited by 9
Comparative deacetylase activity of wild type and mutants of SIRT1
Malik, R., Kashyap, A., Bansal, K., Sharma, P., Rayasam, G., Davis, J. A., Bora, R. S., Ray, A., & Saini, K. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.130 · Cited by 9
“SIRT1 activators are known for regulating diseases of aging and metabolic disorders [19], alternatively, inhibitors for the same are important in regulating cancer [12,21,22].”
BackgroundAl-Sudani, B. T., Ragazzon-Smith, A., Aziz, A., Alansari, R., Ferry, N., Krstic–Demonacos, M., & Ragazzon, P. A. (2020) · RSC Advances · doi:10.1039/d0ra07857c · Cited by 9
SIRT1 suppresses pituitary tumor progression by downregulating PTTG1 expression
Huang, J., Zhang, F., Hu, G., Pan, Y. J., Sun, W., Jiang, L., Wang, P., Qiu, J., & Ding, X. (2022) · Oncology Reports · doi:10.3892/or.2022.8354 · Cited by 11
Kim, Y. R., Kim, S. S., Yoo, N. J., & Lee, S. H. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02560.x · Cited by 9
“Overexpression of SIRT1 in APC ⁄+ mice reduces, instead of increases, colon cancer formation by deacetylating b-catenin (3).”
BackgroundEngineering unnatural cells with a 21st amino acid as a living epigenetic sensor
Hu, Y., Wang, Y., Cheng, L., Wang, C., Liu, Y., Wang, Y., Chen, Y., Yang, S., Guo, Y., Jiang, S. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64448-1 · Cited by 10
“…evidence that SIRT1 can function as a tumor suppressor, for example, Firestein et al. demonstrated that SIRT1 overexpression in APC min/+ mice reduces colon cancer formation, 79 other studies highlight its oncogenic roles, such as promoting cell survival and metabolic reprogramming in cancer cells.”
Sirtuin modulators: a review of patents from 2020 to 2024
Fabbrizi, E., Fiorentino, F., Mai, A., & Rotili, D. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2585821 · Cited by 8
“Its role in cancer, however, is complex and context-dependent [19].”
Simons, C. C. J. M., Schouten, L. J., Godschalk, R., van Schooten, F., van den Brandt, P. A., & Weijenberg, M. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-34728-6 · Cited by 8
Sanaei, M., & Kavoosi, F. (2021) · PubMed Central · doi:10.22037/ijpr.2021.115105.15197 · Cited by 16
Suvarna, B. (2013) · Kathmandu University Medical Journal · doi:10.3126/kumj.v10i2.7350 · Cited by 10
Hong, W. G., & Pyo, J. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.07.022 · Cited by 8
The role of SIRT1 in the development of gastrointestinal tumors
Zhang, Y., Zhou, X., Zhai, J., Ma, J., & Zhang, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1606530 · Cited by 10
“In81human colon tumor specimens and APC min/+ mouse model, the presence of SIRT1 was significantly negatively correlated with the oncogenic form of β-catenin (Firestein et al., 2008).”
Parental SIRT1 Overexpression Attenuate Metabolic Disorders Due to Maternal High-Fat Feeding
Nguyen, L. T., Saad, S., Chen, H., & Pollock, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197342 · Cited by 7
“The Tg mouse colony was acquired from Dr Lindsay Wu (University of New South Wales, Sydney, NSW, Australia) [30].”
MethodLi, C., Hu, S., Yang, L., Wang, M., Long, J.-D., Wang, B., Han, H., Zhu, H., Zhao, S., Liu, J., et al. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00559 · Cited by 7
SIRTing through Breast Cancer Is Just a Survivin' Game
Luo, J., & Altieri, D. C. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.007 · Cited by 7
“The preliminary , October 24, 2008 ª2008 Elsevier Inc. 159 observation that SIRT1 suppresses intestinal tumorigenesis by deacetylating b-catenin (Firestein et al., 2008) seems to support the overall thesis of Wang et al. for a role in tumor suppression (Figure 1).”
BackgroundHrzic, R., Simons, C. C. J. M., Schouten, L. J., van Engeland, M., van den Brandt, P. A., & Weijenberg, M. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-60300-2 · Cited by 8
Hattori, Y., Tahara, S., Ozawa, H., Morita, A., & Ishii, H. (2024) · Neuroendocrinology · doi:10.1159/000539017 · Cited by 7
“Furthermore, the identi fi cation of mitochondrial dysfunction and Sirtuin signaling pathway inactivation aligns with the cellular behaviors commonly observed in tumor cells [27, 31, 32].”
SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma
Chosokabe, M., Noguchi, A., Hoshikawa, M., Masuzawa, M., & Takagi, M. (2019) · Anticancer Research · doi:10.21873/anticanres.13223 · Cited by 7
PPAR Modulation Through Posttranslational Modification Control
Videira, N. B., Dias, M. M. G., Terra, M. F., de Oliveira, V. M., García‐Arévalo, M., Avelino, T. M., Torres, F. R., Batista, F. A. H., & Figueira, A. C. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_21 · Cited by 8
Role of sirtuins in esophageal cancer: Current status and future prospects
Otsuka, R., Hayano, K., & Matsubara, H. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i4.794 · Cited by 7
Xu, L., Cao, Y., Zhang, S., Du, L., Wang, W., Liu, J., Wang, D., Zhao, D., Cui, M., Jiang, S., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111400 · Cited by 6
Controversial Impact of Sirtuins in Chronic Non-Transmissible Diseases and Rehabilitation Medicine
Mongelli, A., & Gaetano, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103080 · Cited by 6
“In this setting, the animals showed a four-fold reduction in size and number of adenomas in the small intestine and colon [38].”
BackgroundKikuchi, K., Noguchi, A., Takahashi, H., Zheng, H., Kameda, Y., Sekiguchi, H., Akaike, M., Miyagi, Y., & Takano, Y. (2013) · journal of cancer therapeutics and research · doi:10.7243/2049-7962-2-1 · Cited by 8
“Observations in the animal models suggest that SIRT1 is somewhat suppressive for colorectal cancers [14,26].”
BackgroundSmall Molecule Modulators of Sirtuin Activity
Alcain, F. J., Minor, R. K., Villalba, J. M., & de Cabo, R. (2010) · Springer eBooks · doi:10.1007/978-90-481-3999-6_10 · Cited by 7
Inhibition of SIRT1 Transcription in Resveratrol-differentiated Medulloblastoma Cells
Ma, J., Li, H., Cheng, X., Wu, M., Li-jun, Y., Kong, Q., Liu, M., & Liu, J. (2013) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v3i5.56 · Cited by 5
“It prevents cell aging and apoptosis of normal cells [35, 36], while the data obtained from human cancers are controversial because this protein is considered as a tumor promoter in neuroblastomas as well as prostate and skin cancers [37-39], but as a tumor suppressor in colon and breast cancers [40, 41].”
BackgroundCalorie Restriction and Cancer Prevention: Established and Emerging Mechanisms
Hursting, S. D., Ford, N. A., Dunlap, S. M., Hursting, M. J., & Lashinger, L. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_14 · Cited by 5
Zhang, W., & Luo, P. (2018) · Oncology Letters · doi:10.3892/ol.2018.8801 · Cited by 5
“Sirtuin 1 (SIRT1) can function as either a tumor suppressor or an oncogene during cancer development, and upregulation of SIRT1 is able to suppress colon cancer growth (12).”
Sirtuin 1 Expression in Canine Mammary Tumors: A Pilot Study
Sgadari, M., Cacciola, N. A., Power, K., Martano, M., & Restucci, B. (2023) · Animals · doi:10.3390/ani13162609 · Cited by 5
Sirtuins – universal regulators of cell function
Кайдашев, І. П. (2012) · Biopolymers and Cell · doi:10.7124/bc.000033 · Cited by 8
Cai, X., Yang, L.-B., Zhou, J., Zhu, D., Guo, Q., Chen, Z., Chen, S., & Zhou, L. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.06.010 · Cited by 5
Ali, F. E., Abdelhafez, A. H., Rabea, S. M., Alzahrani, A. Y. A., Mohammed, A. F., & Youssif, B. G. M. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.145800 · Cited by 4
Hosseinzadeh, A., Seirafianpour, F., Sheibani, M., Taheri, M., Naeini, A. J., Reiter, R. J., & Mehrzadi, S. (2025) · Current Drug Targets · doi:10.2174/0113894501360934250512052503 · Cited by 5
SIRT1 Controls Enteroendocrine Progenitor Cell Proliferation in High-Fat Diet-Fed Mice
Miura, M., Igarashi, M., Isotani, R., Nakagawa-Nagahama, Y., Kuranami, S., Naruse, K., Kadowaki, T., & Yamauchi, T. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.08.006 · Cited by 4
“19 Because K49 previously was shown to be deacetylated by SIRT1, 20,21 we assessed the acetylation status of b -catenin in HFD-VilKO, HFD-NgnKO, and HFD-Sir2d mice using the acetyl-b -catenin (K49) antibody.”
MethodDisruption of Igfbp1 fails to rescue the phenotype of Sirt1−/− mice
Boily, G., He, X. H., Jardine, K. E., & McBurney, M. W. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.012 · Cited by 4
Oxidative Stress in Vascular Aging
Csiszár, A., & Ungvari, Z. I. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-600-9_13 · Cited by 4
Sirtuin Activation by Small Molecules
Massudi, H., Wu, L. E., & Sinclair, D. A. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_12 · Cited by 4
Self-citationSutphin, G. L., & Kaeberlein, M. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00010-5 · Cited by 6
“…transgenic mice are reported to have improved metabolic profiles (Banks et al., 2008; Bordone et al., 2007) and show resistance to colon cancer (Firestein et al., 2008). one surprising feature of the longevity-promoting functions of sirtuins is the apparently distinct mechanisms by which they…”
BackgroundSunami, Y., Araki, M., Hironaka, Y., Morishita, S., Kobayashi, M., Liew, E. L., Edahiro, Y., Tsutsui, M., Ohsaka, A., & Komatsu, N. (2013) · PLoS ONE · doi:10.1371/annotation/36fa9e18-5e99-466d-b10d-dc67cfd14682 · Cited by 4
Calories and Cancer: The Role of Insulin-Like Growth Factor-1
Hursting, S. D., Smith, S. D., Harvey, A. E., & Lashinger, L. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0598-6_12 · Cited by 3
Nuclear β-catenin: molecular regulation, challenges and therapeutic opportunities
Xie, B., Cao, Y., Li, W., Chen, R., Zhou, Q., & Xie, X. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02600-6 · Cited by 8
“Overexpression of SIRT1 in CRC cells significantly reduces the nuclear β-catenin pool by deacetylating β-catenin and keeping it in the cyto-plasm [80].”
Ungvari, Z. I., Menyhárt, O., Ocana, A., Lehoczki, A., Fekete, M., Bianchini, G., & Győrffy, B. (2026) · GeroScience · doi:10.1007/s11357-026-02143-9 · Cited by 3
“As NAD ⁺ -dependent deacetylases, they act as metabolic sensors linking cellular energy status to genome stability, mitochondrial function, and stress resistance— core processes at the intersection of aging and cancer [40, 98–101].”
SIRT1 activators as novel therapy for cancer
Joudah, M. S., Al-Sudani, B. T., & Arif, I. S. (2019) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.19.03.0410 · Cited by 3
Kciuk, M., & Kontek, R. (2020) · Postępy Biochemii · doi:10.18388/pb.2020_319 · Cited by 4
The diverse genomic mechanisms of action of the vitamin D receptor
White, J. H., Sarmadi, F., & Artusa, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00043-x · Cited by 3
Mechanism of regulating deacetylase SIRT1 expression and activity
Yang, W., Wang, D., & Zhu, W. (2011) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2010.01003 · Cited by 3
“SIRT1 对于结肠癌的发生起到的是抑制作用。这主 要是因为存在于细胞核内的β连环蛋白是一种致癌 形式, 而SIRT1 可以对β连环蛋白进行去乙酰化进而 使β连环蛋白重新定位于细胞浆内, 这样β连环蛋白 在导致癌症过程中的活性就被SIRT1抑制([33])。 由此我们可以想到, 既然 SIRT1 在一些情况下可”
BackgroundDiverse Mechanisms of Transcriptional Regulation by the Vitamin D Receptor
White, J. H., Salehi-Tabar, R., Dimitrov, V., & Bouttier, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00010-0 · Cited by 5
Modulation of Tumorigenesis by Dietary Intervention Is Not Mediated by SIRT1 Catalytic Activity
Clark-Knowles, K. V., Dewar‐Darch, D., Jardine, K. E., & McBurney, M. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112406 · Cited by 2
“This suggests that Sirt1 may have the properties of a tumor suppressor gene and several studies have suggested that this may be the case [30–33].”
BackgroundShukla, D., Matore, B. W., Murmu, A., Gawande, P., Roy, P. P., & Singh, J. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2605010 · Cited by 2
Nakhaei, A., Afshari, S., Mohatshami, E., Jalili‐Nik, M., Jalali, M., Abass, K. S., Afshari, A. R., Kesharwani, P., & Sahebkar, A. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105127 · Cited by 3
Metadata
- Authors
- Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., Hahn, W. C., Guarente, L. P., & Sinclair, D. A.
- Affiliations
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sinclair, David A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e2020
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2289879
- OpenAlex
- W2158153532
- Cited by
- 588
- References
- 34
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 12 · 2023: 29 · 2022: 11 · 2021: 25 · 2020: 15 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 38 · 2015: 31 · 2014: 40 · 2013: 60 · 2012: 46
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-06-06)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Glenn Foundation for Medical Research
- National Space Biomedical Research Institute
- National Institutes of Health (NIH T32)
- National Institute on Aging (R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- SIRT1, NAD+-dependent deacetylase, caloric restriction, intestinal tumorigenesis, colon cancer, β-catenin, protein deacetylation, cytoplasmic localization, cell proliferation, longevity genes
- MeSH terms
- Animals, Cell Nucleus, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Models, Biological, Rats, Inbred F344, Gene Expression Regulation, Neoplastic, Sirtuins, Cell Proliferation, beta Catenin, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.